Profile

Kendra M. Smith, MD

Kendra M. Smith, MD

Neonatology

On staff since February 2001

Children's Title: Member Extracorporeal Life Support Steering Committee, Co-Medical Director Seattle Children's ICU Transport Team

Academic Title: Clinical Associate Professor of Pediatrics

Research Center: Center for Developmental Therapeutics

"I find great joy in taking care of babies and seeing their bright faces and little blinking eyes as they see the world for the very first time going home at the end of an arduous day with a smile on my face knowing that Ive made a difference in a patients life connecting with a family as a physician, providing just that extra touch on the arm or hug that says "I am here to help you through this"... working with colleagues who have different specialty interests knowing that if I need advice about a patient they are always there for me being surrounded by a team of nurses, RTs and social workers who can make miracles happen in a crisis being a neonatologist working at Seattle Childrens"

In conjunction with her clinical interests, Dr. Kendra Smith is the principle investigator for two industry-sponsored clinical studies looking at improving the outcome of infants with persistent pulmonary hypertension. She is also working with liquid assisted ventilation to better protect the lungs in neonates severely ill requiring the respirator or extracorporeal life support.

Dr. Smith is involved in the Extracorporeal Life Support Program at Seattle Children's Hospital and serves on the Steering Committee, which focuses on improving techniques to maximally support newborn infants with severe respiratory failure not responsive to conventional therapies. As well, she serves as the Medical Director of the Seattle Children's Ground Transport Team and is an advisor for Airlift Northwest's Neonatal Transport services.

Recommendations

  • Erin Missoula, MT 12.02.10

    My husband and I strongly recommend Dr. Smith as an incredibly knowledgable, compassionate doctor. We truly felt that Dr. Smith was treating our daughter as if she were her own daughter. Thank you so much.

Overview

Board Certification(s)

Neonatal-Perinatal Medicine

Medical/Professional School

University of Minnesota , Minneapolis

Residency

Pediatrics, University of Minnesota , Minneapolis

Fellowship

Neonatal-Perinatal Medicine, University of Minnesota , Minneapolis

Clinical Interests

Potential effects of narcotics and sedatives on the developing brain, Family centered care, Parent brochures reviewing information on problems infants can have in the newborn period

Publications

  • Kendra M. Smith, MD
    Is age at initiation of extracorporeal life support associated with mortality and intraventricular hemorrhage in neonates with respiratory failure?
    J Perinatol , 2014 : 34(5)386-391
  • McMullan DM, Thiagarajan RR, Smith KM, Rycus PT, Brogan TV
    Extracorporeal cardiopulmonary resuscitation outcomes in term and premature neonates*.
    Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies , 2014 Jan. : 15(1)e9-e16
  • Kendra M. Smith, MD
    Extracorporeal life support in neonates
    Neonatology, 7th edition , 2013

Presentations

Presentations Title Event Location Date
Use of the IPad for direct MCP consultation on transport HIMSS and Seattle Children's Mobile Health Tech Talk Seattle, WA March 26, 2014
Volume Guarantee: Facts, Strategies and Case Studies in Neonatal Ventilation CCANN Conference "New Horizons in Neonatal Pulmonary Care Childrens Hospital of Central California, Madera, CA April 27, 2013
Lines, Loops and Lessons Learned, Ventilating the Critically Ill Newborn Annual Dr. Enok Lohne Memorial Current Concepts and Innovations in Respiratory Care Madera, CA April 26, 2013
Lines, Loops and Lessons Learned Alta Bates Hospital Oakland, CA Feb. 21, 2012

Research Funding

Grant Title Grantor Amount Award Date
A multi-center, randomized, placebo-controlled, double-blind, two-armed, parallel group study to evaluate efficacy and safety of IV Sildenafil in the treatment of neonates with persistent pulmonary hypertension of the newborn or hypoxic respiratory failure and at risk for persistent pulmonary hypertension, with a long term follow-up investigation of developmental progress 12 and 24 months after completion of study treatment. Pfizer Pharmaceutical Company $51,827
Partial liquid ventilation for lung protection in congenital diaphragmatic hernia (CDH) patients on ECLS Seattle Childrens Hospital -Academic Enrichment Fund $50,000